Cathy Bolger
About Cathy Bolger
Cathy Bolger is the Director of Scientific Writing at Bristol-Myers Squibb in New Jersey, with extensive experience in the biopharmaceutical and medical device industries.
Company
Cathy Bolger is currently the Director of Scientific Writing at Bristol-Myers Squibb in New Jersey, United States. In this role, she engages in the development of scientific, clinical, and regulatory documents for the company.
Education and Expertise
Cathy Bolger holds a Master of Arts in Biology from San Francisco State University and a Bachelor of Arts in English from Boston College. Her extensive expertise includes creating educational materials for biopharmaceuticals, medical devices, diagnostic kits, biostatistical software tools, and genomic databases.
Previous Roles in Biotech and Medical Industries
From 1997 to 2015, Cathy Bolger worked as a consultant and writer/editor for multiple biotech clients. Her career also spans roles as Marketing Director at Greenleaf Medical from 1994 to 1997, and as Product Manager at Bio-rad Laboratories from 1989 to 1994. Earlier, she worked as a Product Manager at Alcon from 1986 to 1989, and at Me, Myself and I from 1984 to 1986. Her career began as a Research Associate at UCSF from 1980 to 1984.
Collaborative Projects
Cathy Bolger collaborates closely with various scientific and medical groups, including drug discovery, pharmacology, toxicology, regulatory, clinical operations, biostatistics, drug safety, and CMC teams. Her collaborative efforts ensure comprehensive and accurate documentation and communication within the company.
Industry Research and Publications
Cathy Bolger conducts extensive industry research and market intelligence, analyzing unmet medical needs, competing products, scientific literature, and FDA/ICH guidances. Additionally, she has authored a wide range of scientific, clinical, and regulatory publications, contributing valuable insights to the field.